A spokesperson for Eli Lily did not immediately respond to a request for comment on when its own drug's sales would begin in China or how many doses would be supplied. Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro, also approved in China, and weight-loss drug Zepbound.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/w3ckG7U
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment